A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome

Rheumatology (United Kingdom)

Volumn 56, Issue 3, 2017, Pages 362-370

  Jasiek, Magali ^a   Karras, Alexandre ^b   Guern, Véronique Le ^c   Krastinova, Evguenia ^a   Mesbah, Rafik ^d   Faguer, Stanislas ^e   Jourde Chiche, Noemie ^f   Fauchais, Anne Laure ^g   Chiche, Laurent ^h   Dernis, Emmanuelle ^d   Moulis, Guillaume ⁱ   Fraison, Jean Baptiste ^j   Lazaro, Estibaliz ^k   Jullien, Perrine ^l   Hachulla, Eric ^m   Quellec, Alain Le ⁿ   Rémy, Philippe ^o   Hummel, Aurélie ^p   Costedoat Chalumeau, Nathalie ^c   Ronco, Pierre ^q   Vanhille, Philippe ^r   Meas Yedid, Vannary ^s   Cordonnier, Carole ^t   Ferlicot, Sophie ^a   Daniel, Laurent ^f   Seror, Raphaele ^a,u   Mariette, Xavier ^a,u   Thervet, Eric ^b   François, Hèléne ^a   Terrier, Benjamin ^c   more..

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c Université Paris Descartes ^*  (France)

^d CENTRE HOSPITALIER   (France)

^e CHU RANGUEIL   (France)

^f HÔPITAL DE LA CONCEPTION   (France)

^g DUPUYTREN UNIVERSITY HOSPITAL   (France)

^h Department of Internal Medicine   (France)

ⁱ Department of Internal Medicine   (France)

^j Centre Hospitalier Beziers   (France)

^k HAUT LÉVÊQUE HOSPITAL   (France)

^l UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^m LILLE UNIVERSITY HOSPITAL   (France)

ⁿ HÔPITAL SAINT ELOI   (France)

^o HENRI MONDOR HOSPITAL   (France)

^p HÔPITAL NECKER ENFANTS MALADES   (France)

^q HÔPITAL TENON   (France)

^r CENTRE HOSPITALIER DE VALENCIENNES   (France)

^s INSTITUT PASTEUR   (France)

^t AMIENS UNIVERSITY HOSPITAL   (France)

^u INSERM U1184   (France)

more..

Author keywords

Cryoglobulinaemia; Primary sj gren's syndrome; Tubulointerstitial nephritis

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CRYOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LA ANTIBODY; PREDNISONE; RITUXIMAB; RO ANTIBODY; SS-A ANTIBODIES; SS-B ANTIBODIES;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; BREAST CANCER; CELIAC DISEASE; CELL INFILTRATION; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL OUTCOME; COHORT ANALYSIS; COMBINATION DRUG THERAPY; CONSENSUS; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TREATMENT FAILURE; ELECTROLYTE DISTURBANCE; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; EULAR SJOGREN SYNDROME DISEASE ACTIVITY INDEX; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULOPATHY; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY CALCIFICATION; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY FUNCTION; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINOR SALIVA GLAND; MULTIPLE CYCLE TREATMENT; MUSCULOSKELETAL DISEASE ASSESSMENT; MYASTHENIA GRAVIS; NEPHROLITHIASIS; PLASMA CELL; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDY; SALIVARY GLAND BIOPSY; SEPTIC SHOCK; SEVERE RENAL IMPAIRMENT; SJOEGREN SYNDROME; STEROID THERAPY; TREATMENT REFUSAL; TREATMENT RESPONSE; B LYMPHOCYTE; BIOPSY; CLINICAL TRIAL; FRANCE; GLOMERULUS; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; NEPHRITIS, INTERSTITIAL; PATHOLOGY; RENAL INSUFFICIENCY; SJOGREN'S SYNDROME; T LYMPHOCYTE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; B-LYMPHOCYTES; BIOPSY; CRYOGLOBULINS; FEMALE; FRANCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; PLASMA CELLS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RITUXIMAB; SJOGREN'S SYNDROME; T-LYMPHOCYTES; YOUNG ADULT;

EID: 85021855071     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew376     Document Type: Article

References (23)

1. Goules AV, Tatouli IP, Moutsopoulos HM, Tzioufas AG. Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome. Arthritis Rheum 2013;65:2945-53.
2. Ramos-Casals M, Brito-Zeró n P, Solans R et al. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology 2014;53:321-31.
3. Gottenberg J-E, Seror R, Miceli-Richard C et al. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort. PloS One 2013;8:e59868.
4. Bossini N, Savoldi S, Franceschini F et al. Clinical and morphological features of kidney involvement in primary Sjögren's syndrome. Nephrol Dial Transplant 2001;16:2328-36.
5. Goules A, Masouridi S, Tzioufas AG et al. Clinically significant and biopsy-documented renal involvement in primary Sjögren syndrome. Medicine 2000;79:241-9.
6. Ren H, Wang W-M, Chen X-N et al. Renal involvement and followup of 130 patients with primary Sjögren's syndrome. J Rheumatol 2008;35:278-84.
7. Maripuri S, Grande JP, Osborn TG et al. Renal involvement in primary Sjögren's syndrome: a clinicopathologic study. Clin J Am Soc Nephrol 2009;4:1423-31.
8. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
9. Maldini C, Seror R, Fain O et al. Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area. Arthritis Care Res 2014;66:454-63.
10. Seror R, Ravaud P, Bowman SJ et al. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010;69:1103-9.
11. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
12. Servais A, Meas-Yedid V, Buchler M et al. Quantification of interstitial fibrosis by image analysis on routine renal biopsy in patients receiving cyclosporine. Transplantation 2007;84:1595-601.
13. Malladi AS, Sack KE, Shiboski SC et al. Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry. Arthritis Care Res 2012;64:911-8.
14. Baldini C, Pepe P, Quartuccio L et al. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology 2014;53:839-44.
15. Guellec D, Cornec D, Jousse-Joulin S et al. Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review. Autoimmun Rev 2013;12:416-20.
16. Laraki R, Chauveau D, Noel LH, Hermine O. [Membranous glomerulonephritis during primary Gougerot-Sjögren syndrome]. Presse Med 2005;34:1069-72.
17. Candon S, Gottenberg JE, Bengoufa D, Chatenoud L, Mariette X. Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren syndrome: correlation with B-cell biomarkers and disease activity. Ann Rheum Dis 2009;68:1208-12.
18. Gottenberg J-E, Busson M, Cohen-Solal J et al. Correlation of serum B lymphocyte stimulator and b2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren's syndrome. Ann Rheum Dis 2005;64:1050-5.
19. Evans RDR, Laing CM, Ciurtin C, Walsh SB. Tubulointerstitial nephritis in primary Sjögren syndrome: clinical manifestations and response to treatment. BMC Musculoskelet Disord 2016;17:2.
20. Saeki T, Kawano M. IgG4-related kidney disease. Kidney Int 2014;85:251-7.
21. Devauchelle-Pensec V, Mariette X, Jousse-Joulin S et al. Treatment of primary Sjögren syndrome with rituximab: a randomized trial. Ann Intern Med 2014;160:233-42.
22. Gottenberg J-E, Cinquetti G, Larroche C et al. Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis 2013;72:1026-31.
23. Terrier B, Krastinova E, Marie I et al. Management of noninfetious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. Blood 2012;119:5996-6004.